Is there a role for erythropoietin in neonatal medicine?

Early Human Development

Volumn 84, Issue 8, 2008, Pages 525-532

  Mainie, Pramod ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Donor exposure; Neonate; Preterm; Rbc transfusion; Recombinant Erythropoietin (rHuEPO); Retinopathy of prematurity

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ABSENCE OF SIDE EFFECTS; ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; ERYTHROPOIESIS; HUMAN; INFECTION RISK; JEHOVAH'S WITNESS; LOW BIRTH WEIGHT; NUTRIENT; PREMATURITY; REVIEW; RISK ASSESSMENT;

ANEMIA, NEONATAL; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; NEONATOLOGY;

EID: 49049103533     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2008.06.002     Document Type: Review

References (65)

1. Widness J.A., Sawyer S.T., Schmidt R.L., and Chestnut D.H. Lack of maternal to fetal transfer of 125I-erythropoietin in sheep. J Dev Physiol 15 (1991) 139-143
2. Zanjani E.D., Pixley J.S., Slotnick N., MacKintosh F.R., Ekhterae D., and Clemons G. Erythropoietin does not cross the placenta into the fetus. Pathobiology 61 3-4 (1993) 211-215
3. Evseenko D.A., and Tsirel'nikov N.I. Role of placenta in the regulation of fetal erythropoiesis. Exp Biol Med 132 5 (2001) 1055-1057
4. Zanjani E.D., Ascensao J.L., McGlave P.B., Banisadre M., and Ash R.C. Studies in the liver to kidney switch of erythropoietin production. J Clin Invest 67 (1981) 1183-1188
5. Widness J.A., Phillips A.F., and Clemons G.K. Erythropoietin levels and erythropoiesis at birth in infants with Potter's syndrome. J Pediatr 117 (1990) 155-158
6. Kling P.J., Schmidt R.L., Roberts R.A., and Widness J.A. Serum erythropoietin levels during infancy: associations with erythropoiesis. J Pediatr 128 (1996) 791-796
7. Strauss R.G. Current issues in neonatal transfusions. Vox Sang 51 (1986) 1-9
8. Schulman I. The anemia of prematurity. J Pediatr 54 (1959) 663-672
9. Zanjani E.D., Poster J., and Burlington H. Liver as primary site of erythropoietin formation in the fetus. J Lab Clin Med 89 (1977) 640-644
10. Dallman P.R. Anemia of prematurity. Annu Rev Med 32 (1981) 143-160
11. Wardrop C.A., Holland B.M., Beale K.E., Jones J.G., and Gray O.P. Nonphysiological anemia of prematurity. Arch Dis Child 53 (1978) 855-860
12. Stockman J.A., Garcia J.F., and Oski F.A. The anemia of prematurity: factors governing the erythropoietin response. N Engl J Med 296 (1977) 647-650
13. Stockman J.A., Graeber J.E., Clark D.A., McClellan K., Garcia J.F., and Kavey R.E. Anemia of prematurity: determinants of the erythropoietin response. J Pediatr 105 (1984) 786-792
14. Shannon K.M., Naylor G.S., Torkildson J.C., Clemons A.K., Schaffner V., and Goldman S.L. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 31 (1987) 728-733
15. Widness J.A., Seward V.J., Kromer I.J., Burmeiser L.F., and Bell E.F. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 129 (1996) 680-687
16. Franz A.R., and Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?. Arch Dis Child Fetal Neonatal Ed 84 (2001) 96-100
17. British Committee for Standards in Heamatology. Transfusion guidelines for neonates and older children. Br J Haematol 24 (2004) 433-453
18. Liu E.A., Mannino F.L., and Lane T.A. Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr 125 1 (1994) 92-96
19. Shannon K.M., Mentzer W.C., Abels R.I., Freeman P., Newton N., Thompson D., and Phibbs R.H. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr 118 (1991) 949-955
20. Widness J.A., Pedersen P.V., Modi N.B., Schmidt R.L., and Chestnut D.H. Developmental changes in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheep. Pharmacol Exp Ther 261 (1992) 977-984
21. Brown M.S., Jones M.A., Ohls R.K., and Christensen R.D. Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration. J Pediatr 122 (1993) 655-657
22. Maier R.F., Obladen M., Scigalla P., Linderkamp O., Duc G., Hieronimi G., et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 330 (1994) 1173-1178
23. Carnielli V., Montini G., Da Riol R., Dall'Amico R., and Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 121 (1992) 98-102
24. Shannon K.M., Keith III J.F., Mentzer W.C., Ehrenkranz R.A., Brown M.S., Widness J.A., et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 95 (1995) 1-8
25. Ohls R.K., Ehrenkrantz R.A., Wright L.L., Lemons J.A., Korones S.B., Stoll B.J., et al. The effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized controlled trial. Pediatrics 108 (2001) 934-942
26. Ohls R.K., Harcum J., Schibler K.R., and Christensen R.D. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double blind, placebo controlled study. J Pediatr 131 (1997) 661-665
27. Maier R.F., Obladen M., Muller-Hansen I., Kattner E., Merz U., Arlettaz R., et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 141 (2002) 8-15
28. Al-Kharfy T., Smyth J.A., Wadsworth L., Krystal G., Fitzgerald C., Davis J., et al. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 129 (1996) 89-96
29. Meyer M.P., Rous J., and Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants. Proceedings of the European Society for Paediatric Research, Helsinki (Abstract 36) (2001)
30. Bifano E.M., and Curran T. Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 22 (1995) 657-669
31. Ohls R.K., Osborne K.A., and Christensen R.D. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo controlled trial. J Pediatr 126 (1995) 421-426
32. Maier R.F., Sonntag J., Walka M.M., Liu G., Metze B., and Obladen M. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 136 (2000) 220-224
33. Maier R.F., Obladen M., Kattner E., Natzschka J., Messer J., Regazzoni B.M., et al. High-versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr 132 (1998) 866-870
34. Bell E.F., Strauss R.G., Widness J.A., Mahoney L.T., Mock D.M., Seward V.J., et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 115 6 (2005) 1685-1691
35. Kirpalani H., Whyte R.K., Andersen C., Asztalos E.V., Heddle N., Blajchman M.A., et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 149 (2006) 301-307
36. Zipursky A. Erythropoietin therapy for premature infants: cost without benefit?. Pediatr Res 48 (2000) 136
37. Ohlsson A., and Aher S.M. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 3 (2006)
38. Vamvakas E.C., and Strauss R.G. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 41 (2001) 406-415
39. Garcia M.G., Hutson A.D., and Christensen R.D. Effect of recombinant erythropoietin on "Late" transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol 22 (2002) 108-111
40. Kotto-Kome A.C., Garcia M.G., Calhoun D.A., and Christensen R.D. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis. J Perinatol 24 (2004) 24-29
41. Giblett E.R., Varela J.E., and Finch C.A. Damage to the bone marrow due to Rh antibody. Pediatrics 17 (1956) 37-44
42. Thorp J.A., O'Connor T., Callenbach J., Cohen G.R., Yeast Y.D., Albin J., et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol 165 (1991) 79-81
43. Koenig J.M., Ashton R.D., De Vore G.R., and Christensen R.D. Late hyporegenerative anemia in Rh hemolytic disease. J Pediatr 115 (1989) 315-318
44. Al-Alaiyan S., and Omran A.A. Late hyporegenerative anemia in neonates with rhesus hemolytic disease. J Perinat Med 27 (1999) 112-115
45. Dallacasa P., Ancora G., Miniero R., Gavella B., Brondelli L., Conte R., et al. Erythropoietin course in newborns with Rh hemolytic disease transfused and not transfused in utero. Pediatr Res 40 (1996) 357-360
46. Ovali F., Samanci N., and Dagoglu T. Management of late anemia in rhesus hemolytic disease: use of recombinant human erythropoietin (A pilot study). Pediatr Res 39 5 (1996) 831-834
47. Wacker P., Ozsahin H., Stelling M., and Humbert J. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant erythropoietin. Pediatr Hematol Oncol 18 (2001) 279-282
48. Pessler F., and Hart D. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin. J Pediatr Hematol Oncol 24 8 (2002) 689-693
49. Woolley S. Children of Jehovah's Witnesses and adolescent Jehovah's Witnesses: what are their rights?. Arch Dis Child 90 (2005) 715-719
50. Wei L., Han B.H., Li Y., Keough C.L., Holtzman D.M., and Yu S.P. Cell death mechanisms and protective effect of erythropoietin after focal ischaemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317 (2006) 109-116
51. Demers E.J., McPherson R.J., and Juul S. Erthropoietin protects dopaminergic neurons and improves neurobehavioural outcomes in juvenile rats after hypoxia-ischaemia. Pediatr Res 58 (2005) 297-301
52. Strunk T., Härtel C., and Schultz C. Does erythropoietin protect the preterm brain?. Arch Dis Child Fetal Neonatal Ed 89 (2004) F364-366
53. Kumral A., Baskin H., Duman N., Yilmaz O., Tatli M., Ozer E., et al. Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation. Biol Neonate 84 (2003) 325-329
54. Ledbetter J., and Juul S.E. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg 35 (2000) 178-182
55. Juul S.E. Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates. J Pediatr 143 (2003) 321-326
56. Pasha Y.Z., Ahmadpour-Kacho M., Hajiahmadi M., and Hosseini M.B. Enteral erythropoietin increases plasma erythropoietin level in preterm infants: a randomized controlled trial. Indian Pediatr 45 (2008) 25-28
57. Halperin D.S., Wacker P., Lacourt G., Felix M., Babel J.F., Aapro M., et al. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr 116 (1990) 779-786
58. Romagnoli C., Zecca E., Gallini F., Girlando P., and Zuppa A.A. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?. Eur J Pediatr 159 (2000) 627-628
59. Ohls R.K., Ehrenkranz R.A., Das A., Dusick A.M., Yolton K., Romano E., et al. Neurodevelopmental outcome and growth at 18-22 months in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114 (2004) 1287-1291
60. Ohls R.K. The use of erythropoietin in neonates. Clin Perinatol 27 (2000) 681-696
61. Carnielli V.P., Da Riol R., and Montini G. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants. Arch Dis Child Fetal Neonatal Ed 79 (1998) 44-48
62. Meyer M.P., Haworth C., Meyer J.H., and Cammerford A. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 129 (1996) 258-263
63. Becroft D.M.O., Dix M.R., and Farmer K. Intramuscular iron-dextran and suscepitibility of neonates to bacterial infections. Arch Dis Child 52 (1977) 778-781
64. Pathak A., Roth P., Piscitelli J., and Johnson L. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity. Arch Dis Child Fetal Neonatal Ed 88 (2003) F324-F328
65. Bolton-Maggs P.H.B., and Murphy M.F. Blood transfusion. Arch Dis Child 89 (2004) 4-7